- Home
- TARA vs INO Comparison
TARA vs INO Comparison
Compare TARA & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- INO
- Stock Information
- Founded
- TARA N/A
- INO 1979
- Country
- TARA United States
- INO United States
- Employees
- TARA N/A
- INO 134
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- INO Medical/Dental Instruments
- Sector
- TARA Health Care
- INO Health Care
- Exchange
- TARA Nasdaq
- INO Nasdaq
- Market Cap
- TARA 118.1M
- INO 128.1M
- IPO Year
- TARA N/A
- INO 1998
- Fundamental
- Price
- TARA $4.98
- INO $2.62
- Analyst Decision
- TARA Strong Buy
- INO Buy
- Analyst Count
- TARA 6
- INO 5
- Target Price
- TARA $19.80
- INO $8.80
- AVG Volume (30 Days)
- TARA 723.1K
- INO 1.1M
- Earning Date
- TARA 11-11-2025
- INO 11-13-2025
- Dividend Yield
- TARA N/A
- INO N/A
- EPS Growth
- TARA N/A
- INO N/A
- EPS
- TARA N/A
- INO N/A
- Revenue
- TARA N/A
- INO $182,337.00
- Revenue This Year
- TARA N/A
- INO N/A
- Revenue Next Year
- TARA N/A
- INO $15,960.33
- P/E Ratio
- TARA N/A
- INO N/A
- Revenue Growth
- TARA N/A
- INO N/A
- 52 Week Low
- TARA $1.60
- INO $1.30
- 52 Week High
- TARA $10.48
- INO $5.83
- Technical
- Relative Strength Index (RSI)
- TARA 74.50
- INO 53.44
- Support Level
- TARA $4.81
- INO $2.28
- Resistance Level
- TARA $5.12
- INO $2.58
- Average True Range (ATR)
- TARA 0.35
- INO 0.13
- MACD
- TARA 0.10
- INO -0.03
- Stochastic Oscillator
- TARA 86.70
- INO 38.10
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.